Over the next decade, new technologies such as robotics, automation, and advanced analytics, will shape how medicines are produced at large factories in India.
India’s pharma majors are increasingly warming up to the “smart quality” approach; they are trying to use the new-age technologies that characterise Industry 4.0 (also known as the Fourth Industrial Revolution or 4IR) to disrupt the way pills are made.
Why is this shift happening?
The key lies in increasing productivity and reducing human error. According to a McKinsey report, average performing labs could achieve an even larger productivity improvement of 150-200 per cent of their